{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T19:29:47Z","timestamp":1770838187205,"version":"3.50.1"},"reference-count":80,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,17]],"date-time":"2025-05-17T00:00:00Z","timestamp":1747440000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,17]],"date-time":"2025-05-17T00:00:00Z","timestamp":1747440000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Student Research Committee, Shahid Beheshti University of Medical Sciences, Tehran, Iran.","award":["NO. 1402\/66629"],"award-info":[{"award-number":["NO. 1402\/66629"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Complement Med Ther"],"DOI":"10.1186\/s12906-025-04911-0","type":"journal-article","created":{"date-parts":[[2025,5,17]],"date-time":"2025-05-17T13:51:44Z","timestamp":1747489904000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The effects of policosanol supplementation on creatinine: a systematic review and dose\u2013response meta-analysis of randomized controlled trials"],"prefix":"10.1186","volume":"25","author":[{"given":"Mohammad Reza","family":"Amini","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara Sadeghi","family":"Majd","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marieh","family":"Salavatizadeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Farhang","family":"Djafari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gholamreza","family":"Askari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Azita","family":"Hekmatdoost","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,5,17]]},"reference":[{"key":"4911_CR1","doi-asserted-by":"publisher","first-page":"S49","DOI":"10.1016\/j.ymgme.2010.02.020","volume":"100","author":"JT Brosnan","year":"2010","unstructured":"Brosnan JT, Brosnan ME. Creatine metabolism and the urea cycle. Mol Genet Metab. 2010;100:S49\u201352.","journal-title":"Mol Genet Metab"},{"issue":"3","key":"4911_CR2","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1152\/physrev.2000.80.3.1107","volume":"80","author":"M Wyss","year":"2000","unstructured":"Wyss M, Kaddurah-Daouk R. Creatine and creatinine metabolism. Physiol Rev. 2000;80(3):1107\u2013213.","journal-title":"Physiol Rev"},{"issue":"6","key":"4911_CR3","doi-asserted-by":"publisher","first-page":"461","DOI":"10.7326\/0003-4819-130-6-199903160-00002","volume":"130","author":"AS Levey","year":"1999","unstructured":"Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D, et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Ann Intern Med. 1999;130(6):461\u201370.","journal-title":"Ann Intern Med"},{"issue":"9","key":"4911_CR4","doi-asserted-by":"publisher","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","volume":"150","author":"AS Levey","year":"2009","unstructured":"Levey AS, Stevens LA, Schmid CH, Zhang Y, Castro AF III, Feldman HI, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604\u201312.","journal-title":"Ann Intern Med"},{"issue":"1","key":"4911_CR5","doi-asserted-by":"publisher","first-page":"e23","DOI":"10.1097\/CCM.0000000000002013","volume":"45","author":"KB Kashani","year":"2017","unstructured":"Kashani KB, Frazee EN, Kukr\u00e1lov\u00e1 L, Sarvottam K, Herasevich V, Young PM, et al. Evaluating muscle mass by using markers of kidney function: development of the sarcopenia index. Crit Care Med. 2017;45(1):e23\u20139.","journal-title":"Crit Care Med"},{"key":"4911_CR6","doi-asserted-by":"publisher","first-page":"1699","DOI":"10.1007\/s00134-018-5359-6","volume":"44","author":"L Hessels","year":"2018","unstructured":"Hessels L, Koopmans N, Gomes Neto AW, Volbeda M, Koeze J, Lansink-Hartgring AO, et al. Urinary creatinine excretion is related to short-term and long-term mortality in critically ill patients. Intensive Care Med. 2018;44:1699\u2013708.","journal-title":"Intensive Care Med"},{"key":"4911_CR7","doi-asserted-by":"crossref","unstructured":"Kalantar-Zadeh K, Streja E, Kovesdy CP, Oreopoulos A, Noori N, Jing J, et al., editors. The obesity paradox and mortality associated with surrogates of body size and muscle mass in patients receiving hemodialysis. Mayo Clinic Proceedings; 2010: Elsevier.","DOI":"10.4065\/mcp.2010.0336"},{"issue":"7","key":"4911_CR8","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1093\/ndt\/gfg074","volume":"18","author":"F Locatelli","year":"2003","unstructured":"Locatelli F, Canaud B, Eckardt KU, Stenvinkel P, Wanner C, Zoccali C. Oxidative stress in end-stage renal disease: an emerging threat to patient outcome. Nephrol Dial Transplant. 2003;18(7):1272\u201380.","journal-title":"Nephrol Dial Transplant"},{"key":"4911_CR9","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1097\/WOX.0b013e3182439613","volume":"5","author":"E Birben","year":"2012","unstructured":"Birben E, Sahiner UM, Sackesen C, Erzurum S, Kalayci O. Oxidative stress and antioxidant defense. World Allergy Organ J. 2012;5:9\u201319.","journal-title":"World Allergy Organ J"},{"issue":"4","key":"4911_CR10","doi-asserted-by":"publisher","first-page":"F367","DOI":"10.1152\/ajprenal.00571.2013","volume":"306","author":"R Che","year":"2014","unstructured":"Che R, Yuan Y, Huang S, Zhang A. Mitochondrial dysfunction in the pathophysiology of renal diseases. American Journal of Physiology-Renal Physiology. 2014;306(4):F367\u201378.","journal-title":"American Journal of Physiology-Renal Physiology"},{"issue":"5","key":"4911_CR11","doi-asserted-by":"publisher","first-page":"346","DOI":"10.3109\/10715762.2013.779373","volume":"47","author":"A Popolo","year":"2013","unstructured":"Popolo A, Autore G, Pinto A, Marzocco S. Oxidative stress in patients with cardiovascular disease and chronic renal failure. Free Radical Res. 2013;47(5):346\u201356.","journal-title":"Free Radical Res"},{"issue":"9","key":"4911_CR12","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1089\/ars.2016.6756","volume":"26","author":"S Spahis","year":"2017","unstructured":"Spahis S, Borys J-M, Levy E. Metabolic syndrome as a multifaceted risk factor for oxidative stress. Antioxid Redox Signal. 2017;26(9):445\u201361.","journal-title":"Antioxid Redox Signal"},{"issue":"15","key":"4911_CR13","doi-asserted-by":"publisher","first-page":"5359","DOI":"10.1021\/jf060688k","volume":"54","author":"P Adhikari","year":"2006","unstructured":"Adhikari P, Hwang KT, Park JN, Kim CK. Policosanol content and composition in perilla seeds. J Agric Food Chem. 2006;54(15):5359\u201362.","journal-title":"J Agric Food Chem"},{"issue":"1","key":"4911_CR14","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/S0188-4409(00)00265-4","volume":"32","author":"R Men\u00e9ndez","year":"2001","unstructured":"Men\u00e9ndez R, Amor AM, Rodeiro I, Gonz\u00e1lez RM, Gonz\u00e1lez PC, Alfonso JL, et al. Policosanol modulates HMG-CoA reductase activity in cultured fibroblasts. Arch Med Res. 2001;32(1):8\u201312.","journal-title":"Arch Med Res"},{"issue":"2","key":"4911_CR15","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1067\/mhj.2002.119997","volume":"143","author":"I Gouni-Berthold","year":"2002","unstructured":"Gouni-Berthold I, Berthold HK. Policosanol: clinical pharmacology and therapeutic significance of a new lipid-lowering agent. Am Heart J. 2002;143(2):356\u201365.","journal-title":"Am Heart J"},{"key":"4911_CR16","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1007\/s11745-011-3540-6","volume":"46","author":"S Banerjee","year":"2011","unstructured":"Banerjee S, Ghoshal S, Porter TD. Activation of AMP-kinase by policosanol requires peroxisomal metabolism. Lipids. 2011;46:311\u201321.","journal-title":"Lipids"},{"issue":"7","key":"4911_CR17","doi-asserted-by":"publisher","first-page":"882","DOI":"10.3109\/09637486.2013.809405","volume":"64","author":"E Barrat","year":"2013","unstructured":"Barrat E, Za\u00efr Y, Ogier N, Housez B, Vergara C, Maudet C, et al. A combined natural supplement lowers LDL cholesterol in subjects with moderate untreated hypercholesterolemia: a randomized placebo-controlled trial. Int J Food Sci Nutr. 2013;64(7):882\u20139.","journal-title":"Int J Food Sci Nutr"},{"issue":"4","key":"4911_CR18","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1111\/j.2042-7158.1995.tb05797.x","volume":"47","author":"M Noa","year":"1995","unstructured":"Noa M, M\u00e1s R, De La Rosa M, Magraner J. Effect of policosanol on lipofundin-induced atherosclerotic lesions in rats. J Pharm Pharmacol. 1995;47(4):289\u201391.","journal-title":"J Pharm Pharmacol"},{"issue":"3","key":"4911_CR19","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1111\/j.2042-7158.1996.tb05922.x","volume":"48","author":"M Noa","year":"1996","unstructured":"Noa M, De la Rosa M, Mas R. Effect of Policosanol on Foam-cell Formation in Carrageenan-induced Granulomas in Rats. J Pharm Pharmacol. 1996;48(3):306\u20139.","journal-title":"J Pharm Pharmacol"},{"issue":"8","key":"4911_CR20","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1016\/S0011-393X(99)80024-1","volume":"60","author":"R Mas","year":"1999","unstructured":"Mas R, Rivas P, Izquierdo JE, Hernandez R, Fern\u00e1ndez L, Fern\u00e1ndez J, et al. Pharmacoepidemiologic study of policosanol. Curr Ther Res. 1999;60(8):458\u201367.","journal-title":"Curr Ther Res"},{"issue":"4","key":"4911_CR21","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.amjopharm.2004.12.004","volume":"2","author":"S Fern\u00e1ndez","year":"2004","unstructured":"Fern\u00e1ndez S, Rosa M, Gamez R, Diaz A, Fern\u00e1ndez J, Illnait J, et al. A pharmacological surveillance study of the tolerability of policosanol in the elderly population. Am J Geriatr Pharmacother. 2004;2(4):219\u201329.","journal-title":"Am J Geriatr Pharmacother"},{"issue":"2","key":"4911_CR22","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/0011-393X(95)85043-0","volume":"56","author":"E Aneiros","year":"1995","unstructured":"Aneiros E, M\u00e1s R, Calderon B, Illnait J, Fern\u00e1ndez L, Casta\u00f1o G, et al. Effect of policosanol in lowering cholesterol levels in patients with type II hypercholesterolemia. Curr Ther Res. 1995;56(2):176\u201382.","journal-title":"Curr Ther Res"},{"issue":"4","key":"4911_CR23","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/S0009-9236(99)70139-6","volume":"65","author":"R M\u00e1s","year":"1999","unstructured":"M\u00e1s R, Casta\u00f1o G, Illnait J, Fern\u00e1ndez L, Fern\u00e1ndez J, Alem\u00e1n C, et al. Effects of policosanol in patients with type II hypercholesterolemia and additional coronary risk factors. Clin Pharmacol Ther. 1999;65(4):439\u201347.","journal-title":"Clin Pharmacol Ther"},{"issue":"1","key":"4911_CR24","doi-asserted-by":"publisher","first-page":"026","DOI":"10.30574\/ijsra.2021.4.1.0046","volume":"4","author":"JC Fern\u00e1ndez-Travieso","year":"2021","unstructured":"Fern\u00e1ndez-Travieso JC, Illnait-Ferrer J, Mendoza-Casta\u00f1o S, Fern\u00e1ndez-Dorta L, G\u00e1mez-Men\u00e9ndez R, L\u00f3pez-Gonz\u00e1lez LE, et al. Long-term effects with policosanol on lipid profile according to hypercholesterolemia severity in older patients. International Journal of Science and Research Archive. 2021;4(1):026\u201338.","journal-title":"International Journal of Science and Research Archive"},{"key":"4911_CR25","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/1479-5876-12-76","volume":"12","author":"N Chatauret","year":"2014","unstructured":"Chatauret N, Favreau F, Giraud S, Thierry A, Rossard L, Le Pape S, et al. Diet-induced increase in plasma oxidized LDL promotes early fibrosis in a renal porcine auto-transplantation model. J Transl Med. 2014;12:76.","journal-title":"J Transl Med"},{"issue":"9","key":"4911_CR26","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1093\/abbs\/gms059","volume":"44","author":"X Yu","year":"2012","unstructured":"Yu X, Xing C, Pan Y, Ma H, Zhang J, Li W. IGF-1 alleviates ox-LDL-induced inflammation via reducing HMGB1 release in HAECs. Acta Biochim Biophys Sin (Shanghai). 2012;44(9):746\u201351.","journal-title":"Acta Biochim Biophys Sin (Shanghai)"},{"issue":"10","key":"4911_CR27","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.3390\/ijms17101647","volume":"17","author":"J Zhan","year":"2016","unstructured":"Zhan J, Wang K, Zhang C, Zhang C, Li Y, Zhang Y, et al. GSPE Inhibits HMGB1 Release, Attenuating Renal IR-Induced Acute Renal Injury and Chronic Renal Fibrosis. Int J Mol Sci. 2016;17(10):1647.","journal-title":"Int J Mol Sci."},{"key":"4911_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.jff.2022.105250","volume":"97","author":"GM Elnagar","year":"2022","unstructured":"Elnagar GM, Elseweidy MM, Elkomy NM, Keshawy MM, Fathy OM, Sobh MS, et al. Policosanol ameliorates renal inflammation and pyroptosis in hypercholesterolemic rabbits via modulation of HMGB1\/PI3K\/mTOR\/NLRP3\/Caspase-1 pathway. Journal of Functional Foods. 2022;97: 105250.","journal-title":"Journal of Functional Foods"},{"issue":"3","key":"4911_CR29","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/S0011-393X(97)80010-0","volume":"58","author":"G Casta\u00f1o","year":"1997","unstructured":"Casta\u00f1o G, M\u00e1s R, Fern\u00e1ndez JC, Illnait J. Comparative effects of two once-daily regimens of policosanol in patients with type II hypercholesterolemia. Curr Ther Res. 1997;58(3):154\u201362.","journal-title":"Curr Ther Res"},{"key":"4911_CR30","unstructured":"Higgins J. Cochrane handbook for systematic reviews of interventions. Version 5.1. 0 [updated March 2011]. The Cochrane Collaboration. www cochrane-handbook org. 2011."},{"issue":"7","key":"4911_CR31","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1000097","volume":"6","author":"D Moher","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6(7): e1000097.","journal-title":"PLoS Med"},{"key":"4911_CR32","unstructured":"Nang C, Piano B, Lewis A, Lycett K, Woodhouse M. Using the PICOS model to design and conduct a systematic search: a speech pathology case study. 2015."},{"key":"4911_CR33","doi-asserted-by":"crossref","unstructured":"Borenstein M, Hedges LV, Higgins JP, Rothstein HR. Introduction to meta-analysis: John Wiley & Sons; 2021.","DOI":"10.1002\/9781119558378"},{"issue":"3","key":"4911_CR34","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","volume":"7","author":"R DerSimonian","year":"1986","unstructured":"DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7(3):177\u201388.","journal-title":"Control Clin Trials"},{"key":"4911_CR35","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/1471-2288-5-13","volume":"5","author":"SP Hozo","year":"2005","unstructured":"Hozo SP, Djulbegovic B, Hozo I. Estimating the mean and variance from the median, range, and the size of a sample. BMC Med Res Methodol. 2005;5:13.","journal-title":"BMC Med Res Methodol"},{"key":"4911_CR36","unstructured":"S F. GetData Graph Digitizer version 2.24 2002. Available from: Get data-graph-digitizer-com."},{"issue":"11","key":"4911_CR37","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1002\/sim.1186","volume":"21","author":"JP Higgins","year":"2002","unstructured":"Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21(11):1539\u201358.","journal-title":"Stat Med"},{"issue":"284","key":"4911_CR38","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1111\/1475-4932.12023","volume":"89","author":"G Foster","year":"2013","unstructured":"Foster G. Interpreting and Visualizing Regression Models Using Stata, by Michael N Mitchell (Stata Press, College Station, Texas, 2012), pp xxix + 558. Econ Rec. 2013;89(284):132\u20134.","journal-title":"Econ Rec."},{"issue":"7109","key":"4911_CR39","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","volume":"315","author":"M Egger","year":"1997","unstructured":"Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315(7109):629\u201334.","journal-title":"BMJ"},{"issue":"7650","key":"4911_CR40","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","volume":"336","author":"GH Guyatt","year":"2008","unstructured":"Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008;336(7650):924\u20136.","journal-title":"BMJ"},{"issue":"3","key":"4911_CR41","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/S0011-393X(05)80631-9","volume":"54","author":"E Aneiros","year":"1993","unstructured":"Aneiros E, Calder\u00f3n B, M\u00e1s R, Illnait J, Casta\u00f1o G, Fern\u00e1ndez L, et al. Effect of successive dose increases of policosanol on the lipid profile and tolerability of treatment. Curr Ther Res. 1993;54(3):304\u201312.","journal-title":"Curr Ther Res"},{"issue":"2","key":"4911_CR42","doi-asserted-by":"publisher","first-page":"36","DOI":"10.14740\/jem642","volume":"10","author":"L Arteche-Hidalgo","year":"2020","unstructured":"Arteche-Hidalgo L, Fernandez-Travieso JC, Suarez-Camejo N, Marin-Preval J, Alvarez-Acosta V, Chaviano-Pereira J, et al. Effects of policosanol in patients with metabolic syndrome: A six-month study. Journal of Endocrinology and Metabolism. 2020;10(2):36\u201344.","journal-title":"Journal of Endocrinology and Metabolism"},{"issue":"8","key":"4911_CR43","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1016\/0011-393X(95)85065-1","volume":"56","author":"G Casta\u00f1o","year":"1995","unstructured":"Casta\u00f1o G, Canetti M, Moreira M, Tula L, M\u00e1s R, Illnait J, et al. Efficacy and tolerability of policosanol in elderly patients with type II hypercholesterolemia: a 12-month study. Curr Ther Res. 1995;56(8):819\u201328.","journal-title":"Curr Ther Res"},{"issue":"9","key":"4911_CR44","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/S0011-393X(96)80074-9","volume":"57","author":"G Casta\u00f1o","year":"1996","unstructured":"Casta\u00f1o G, Tula L, Canetti M, Morera M, M\u00e1s R, Illnait J, et al. Effects of policosanol in hypertensive patients with type II hypercholesterolemia. Curr Ther Res. 1996;57(9):691\u20139.","journal-title":"Curr Ther Res"},{"issue":"3","key":"4911_CR45","doi-asserted-by":"publisher","first-page":"M186","DOI":"10.1093\/gerona\/56.3.M186","volume":"56","author":"G Casta\u00f1o","year":"2001","unstructured":"Casta\u00f1o G, M\u00e1s R, Fern\u00e1ndez JC, Illnait J, Fern\u00e1ndez L, Alvarez E. Effects of policosanol in older patients with type II hypercholesterolemia and high coronary risk. J Gerontol A Biol Sci Med Sci. 2001;56(3):M186\u201392.","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"3","key":"4911_CR46","doi-asserted-by":"publisher","first-page":"159","DOI":"10.2165\/00126839-200203030-00004","volume":"3","author":"G Casta\u00f1o","year":"2002","unstructured":"Casta\u00f1o G, M\u00e1s R, Fern\u00e1ndez JC, Fern\u00e1ndez L, Illnait J, L\u00f3pez E. Effects of policosanol on older patients with hypertension and type II hypercholesterolaemia. Drugs R D. 2002;3(3):159\u201372.","journal-title":"Drugs R D"},{"issue":"8","key":"4911_CR47","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1016\/j.curtheres.2003.09.002","volume":"64","author":"G Casta\u00f1o","year":"2003","unstructured":"Casta\u00f1o G, M\u00e1s R, Fern\u00e1ndez J, L\u00f3pez E, Illnait J, Fern\u00e1ndez L, et al. Effects of policosanol on borderline to mildly elevated serum total cholesterol levels: a prospective, double-blind, placebo-controlled, parallel-group, comparative study. Curr Ther Res. 2003;64(8):522\u201337.","journal-title":"Curr Ther Res"},{"issue":"4","key":"4911_CR48","doi-asserted-by":"publisher","first-page":"207","DOI":"10.2165\/00126839-200506040-00003","volume":"6","author":"G Casta\u00f1o","year":"2005","unstructured":"Casta\u00f1o G, Fern\u00e1ndez L, Mas R, Illnait J, G\u00e1mez R, Mendoza S, et al. Effects of addition of policosanol to omega-3 fatty acid therapy on the lipid profile of patients with type II hypercholesterolaemia. Drugs R D. 2005;6(4):207\u201319.","journal-title":"Drugs R D"},{"issue":"3","key":"4911_CR49","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.curtheres.2006.06.004","volume":"67","author":"G Casta\u00f1o","year":"2006","unstructured":"Casta\u00f1o G, Arruzazabala ML, Fern\u00e1ndez L, Mas R, Carbajal D, Molina V, et al. Effects of combination treatment with policosanol and omega-3 fatty acids on platelet aggregation: A randomized, double-blind clinical study. Curr Ther Res Clin Exp. 2006;67(3):174\u201392.","journal-title":"Curr Ther Res Clin Exp"},{"issue":"3","key":"4911_CR50","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/0011-393X(95)85034-1","volume":"56","author":"G Casta\u00f1o","year":"1995","unstructured":"Casta\u00f1o G, M\u00e1s R, Nodarse M, Illnait J, Fern\u00e1ndez L, Fern\u00e1ndez JC. One-year study of the efficacy and safety of policosanol (5 mg twice daily) in the treatment of type II hypercholesterolemia. Curr Ther Res. 1995;56(3):296\u2013304.","journal-title":"Curr Ther Res"},{"issue":"2","key":"4911_CR51","first-page":"107","volume":"38","author":"G Casta\u00f1o","year":"2007","unstructured":"Casta\u00f1o G, M\u00e1s R, G\u00e1mez R, Fern\u00e1ndez L, Illnait J, Fern\u00e1ndez J, et al. Concomitant use of policosanol and benzodiazepines in older patients. Revista CENIC Ciencias Biol\u00f3gicas. 2007;38(2):107\u201313.","journal-title":"Revista CENIC Ciencias Biol\u00f3gicas"},{"issue":"3","key":"4911_CR52","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/S0011-393X(01)80031-X","volume":"62","author":"G Casta\u00f1o","year":"2001","unstructured":"Casta\u00f1o G, M\u00e1s R, Fern\u00e1ndez L, Illnait J, G\u00e1mez R, Fern\u00e1ndez JC. Comparison of two regimens of policosanol administered at 20 mg\/d in patients with type II hypercholesterolemia: a randomized, double-blind, placebo-controlled study. Curr Ther Res. 2001;62(3):194\u2013208.","journal-title":"Curr Ther Res"},{"issue":"6","key":"4911_CR53","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1016\/S0011-393X(00)80004-1","volume":"61","author":"S Marcello","year":"2000","unstructured":"Marcello S, Gladstein J, Tesone P, M\u00e1s R. Effects of bezafibrate plus policosanol or placebo in patients with combined dyslipidemia: a pilot study. Curr Ther Res. 2000;61(6):346\u201357.","journal-title":"Curr Ther Res"},{"issue":"2","key":"4911_CR54","first-page":"30","volume":"17","author":"B Swanson","year":"2011","unstructured":"Swanson B, Keithley JK, Sha BE, Fogg L, Nerad J, Novak RM, et al. Policosanol for managing human immunodeficiency virus-related dyslipidemia in a medically underserved population: a randomized, controlled clinical trial. Altern Ther Health Med. 2011;17(2):30\u20135.","journal-title":"Altern Ther Health Med"},{"issue":"3","key":"4911_CR55","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.amjms.2018.06.014","volume":"356","author":"HY Wang","year":"2018","unstructured":"Wang HY, Jiao QP, Chen SY, Sheng J, Jiang H, Lu J, et al. Efficacy and Safety of Policosanol Plus Fenofibrate Combination Therapy in Elderly Patients with Mixed Dyslipidemia: A Randomized, Controlled Clinical Study. Am J Med Sci. 2018;356(3):254\u201361.","journal-title":"Am J Med Sci"},{"issue":"7","key":"4911_CR56","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1016\/S0011-393X(96)80068-3","volume":"57","author":"R Zardoya","year":"1996","unstructured":"Zardoya R, Tula L, Casta\u00f1o G, M\u00e1s R, Illnait J, Fern\u00e1ndez JC, et al. Effects of policosanol on hypercholesterolemic patients with abnormal serum biochemical indicators of hepatic function. Curr Ther Res. 1996;57(7):568\u201377.","journal-title":"Curr Ther Res"},{"issue":"6","key":"4911_CR57","doi-asserted-by":"publisher","first-page":"5185","DOI":"10.3390\/ijms24065185","volume":"24","author":"KH Cho","year":"2023","unstructured":"Cho KH, Nam HS, Baek SH, Kang DJ, Na H, Komatsu T, et al. Beneficial Effect of Cuban Policosanol on Blood Pressure and Serum Lipoproteins Accompanied with Lowered Glycated Hemoglobin and Enhanced High-Density Lipoprotein Functionalities in a Randomized, Placebo-Controlled, and Double-Blinded Trial with Healthy Japanese. Int J Mol Sci. 2023;24(6):5185.","journal-title":"Int J Mol Sci."},{"issue":"6","key":"4911_CR58","first-page":"1319","volume":"13","author":"KH Cho","year":"2023","unstructured":"Cho KH, Kim JE, Komatsu T, Uehara Y. Protection of Liver Functions and Improvement of Kidney Functions by Twelve Weeks Consumption of Cuban Policosanol (Raydel(\u00ae)) with a Decrease of Glycated Hemoglobin and Blood Pressure from a Randomized, Placebo-Controlled, and Double-Blinded Study with Healthy and Middle-Aged Japanese Participants. Life (Basel). 2023;13(6):1319.","journal-title":"Life (Basel)."},{"issue":"4","key":"4911_CR59","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/S0011-393X(05)80456-4","volume":"52","author":"P Pons","year":"1992","unstructured":"Pons P, M\u00e1s R, Illnait J, Fern\u00e1ndez L, Rodr\u00edguez M, Robaina C, et al. Efficacy and safety of policosanol in patients with primary hypercholesterolemia. Curr Ther Res. 1992;52(4):507\u201313.","journal-title":"Curr Ther Res"},{"issue":"9","key":"4911_CR60","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1016\/S0011-393X(05)80279-6","volume":"55","author":"P Pons","year":"1994","unstructured":"Pons P, Rodr\u00edguez M, M\u00e1s R, Illnait J, Fern\u00e1ndez L, Robaina C, et al. One-year efficacy and safety of policosanol in patients with type II hypercholesterolemia. Curr Ther Res. 1994;55(9):1084\u201392.","journal-title":"Curr Ther Res"},{"issue":"10","key":"4911_CR61","doi-asserted-by":"publisher","first-page":"1933","DOI":"10.1093\/clinchem\/38.10.1933","volume":"38","author":"RD Perrone","year":"1992","unstructured":"Perrone RD, Madias NE, Levey AS. Serum creatinine as an index of renal function: new insights into old concepts. Clin Chem. 1992;38(10):1933\u201353.","journal-title":"Clin Chem"},{"issue":"1","key":"4911_CR62","doi-asserted-by":"publisher","first-page":"1786","DOI":"10.1038\/s41598-023-28150-w","volume":"13","author":"HJ Kim","year":"2023","unstructured":"Kim HJ, Kim DW, Rhee H, Song SH, Park SK, Kim SW, et al. Rapid decline in kidney function is associated with rapid deterioration of health-related quality of life in chronic kidney disease. Sci Rep. 2023;13(1):1786.","journal-title":"Sci Rep"},{"issue":"9888","key":"4911_CR63","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/S0140-6736(13)60687-X","volume":"382","author":"V Jha","year":"2013","unstructured":"Jha V, Garcia-Garcia G, Iseki K, Li Z, Naicker S, Plattner B, et al. Chronic kidney disease: global dimension and perspectives. Lancet. 2013;382(9888):260\u201372.","journal-title":"Lancet"},{"issue":"5 Suppl 1","key":"4911_CR64","doi-asserted-by":"publisher","first-page":"S40","DOI":"10.1016\/j.amjmed.2006.01.013","volume":"119","author":"A Barnett","year":"2006","unstructured":"Barnett A. Prevention of loss of renal function over time in patients with diabetic nephropathy. Am J Med. 2006;119(5 Suppl 1):S40\u20137.","journal-title":"Am J Med"},{"issue":"1","key":"4911_CR65","doi-asserted-by":"publisher","first-page":"1700280","DOI":"10.1002\/mnfr.201700280","volume":"62","author":"J Gong","year":"2018","unstructured":"Gong J, Qin X, Yuan F, Hu M, Chen G, Fang K, et al. Efficacy and safety of sugarcane policosanol on dyslipidemia: A meta-analysis of randomized controlled trials. Mol Nutr Food Res. 2018;62(1):1700280.","journal-title":"Mol Nutr Food Res."},{"issue":"2","key":"4911_CR66","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1002\/ptr.4705","volume":"27","author":"RM Kaup","year":"2013","unstructured":"Kaup RM, Khayyal MT, Verspohl EJ. Antidiabetic effects of a standardized Egyptian rice bran extract. Phytother Res. 2013;27(2):264\u201371.","journal-title":"Phytother Res"},{"key":"4911_CR67","doi-asserted-by":"publisher","first-page":"4809525","DOI":"10.1155\/2018\/4809525","volume":"2018","author":"KH Cho","year":"2018","unstructured":"Cho KH, Kim SJ, Yadav D, Kim JY, Kim JR. Consumption of Cuban Policosanol Improves Blood Pressure and Lipid Profile via Enhancement of HDL Functionality in Healthy Women Subjects: Randomized, Double-Blinded, and Placebo-Controlled Study. Oxid Med Cell Longev. 2018;2018:4809525.","journal-title":"Oxid Med Cell Longev"},{"issue":"1","key":"4911_CR68","doi-asserted-by":"publisher","first-page":"c20","DOI":"10.1159\/000093255","volume":"104","author":"M Cirit","year":"2006","unstructured":"Cirit M, Toprak O, Yesil M, Bayata S, Postaci N, Pupim L, et al. Angiotensin-converting enzyme inhibitors as a risk factor for contrast-induced nephropathy. Nephron Clin Pract. 2006;104(1):c20\u20137.","journal-title":"Nephron Clin Pract"},{"issue":"11","key":"4911_CR69","first-page":"734","volume":"50","author":"E Br\u00e4ndle","year":"1996","unstructured":"Br\u00e4ndle E, Sieberth HG, Hautmann RE. Effect of chronic dietary protein intake on the renal function in healthy subjects. Eur J Clin Nutr. 1996;50(11):734\u201340.","journal-title":"Eur J Clin Nutr"},{"issue":"8","key":"4911_CR70","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1016\/j.curtheres.2003.09.002","volume":"64","author":"G Casta\u00f1o","year":"2003","unstructured":"Casta\u00f1o G, M\u00e1s R, Fern\u00e1ndez J, L\u00f3pez E, Illnait J, Fern\u00e1ndez L, et al. Effects of policosanol on borderline to mildly elevated serum total cholesterol levels: a prospective, double-blind, placebo-controlled, parallel-group, comparative study. Curr Ther Res Clin Exp. 2003;64(8):522\u201337.","journal-title":"Curr Ther Res Clin Exp"},{"issue":"4","key":"4911_CR71","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1681\/ASN.V114669","volume":"11","author":"JA Joles","year":"2000","unstructured":"Joles JA, Kunter U, Janssen U, Kriz W, Rabelink TJ, Koomans HA, et al. Early mechanisms of renal injury in hypercholesterolemic or hypertriglyceridemic rats. J Am Soc Nephrol. 2000;11(4):669\u201383.","journal-title":"J Am Soc Nephrol"},{"issue":"6","key":"4911_CR72","doi-asserted-by":"publisher","first-page":"2062","DOI":"10.1046\/j.1523-1755.2001.00720.x","volume":"59","author":"FT Stevenson","year":"2001","unstructured":"Stevenson FT, Shearer GC, Atkinson DN. Lipoprotein-stimulated mesangial cell proliferation and gene expression are regulated by lipoprotein lipase. Kidney Int. 2001;59(6):2062\u20138.","journal-title":"Kidney Int"},{"issue":"5","key":"4911_CR73","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1038\/nri2546","volume":"9","author":"AW Thomson","year":"2009","unstructured":"Thomson AW, Turnquist HR, Raimondi G. Immunoregulatory functions of mTOR inhibition. Nat Rev Immunol. 2009;9(5):324\u201337.","journal-title":"Nat Rev Immunol"},{"issue":"9","key":"4911_CR74","doi-asserted-by":"publisher","first-page":"764","DOI":"10.21037\/atm-20-7973","volume":"9","author":"J Li","year":"2021","unstructured":"Li J, Yang X, Yang P, Xu K, Peng X, Cai W, et al. Andrographolide alleviates bleomycin-induced NLRP3 inflammasome activation and epithelial-mesenchymal transition in lung epithelial cells by suppressing AKT\/mTOR signaling pathway. Ann Transl Med. 2021;9(9):764.","journal-title":"Ann Transl Med"},{"issue":"4","key":"4911_CR75","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1159\/000013363","volume":"18","author":"DD Roh","year":"1998","unstructured":"Roh DD, Kamanna VS, Kirschenbaum MA. Oxidative modification of low-density lipoprotein enhances mesangial cell protein synthesis and gene expression of extracellular matrix proteins. Am J Nephrol. 1998;18(4):344\u201350.","journal-title":"Am J Nephrol"},{"key":"4911_CR76","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2022.113020","volume":"150","author":"N Zein","year":"2022","unstructured":"Zein N, Yassin F, Makled S, Alotaibi SS, Albogami SM, Mostafa-Hedeab G, et al. Oral supplementation of policosanol alleviates carbon tetrachloride-induced liver fibrosis in rats. Biomed Pharmacother. 2022;150: 113020.","journal-title":"Biomed Pharmacother"},{"issue":"3","key":"4911_CR77","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccmp.2022.100058","volume":"2","author":"LK Olatunji","year":"2022","unstructured":"Olatunji LK, Jimoh AO, Tukur UM, Imam MU. A Review of the Effects of Policosanol on Metabolic Syndrome. Clinical Complementary Medicine and Pharmacology. 2022;2(3): 100058.","journal-title":"Clinical Complementary Medicine and Pharmacology"},{"issue":"17","key":"4911_CR78","doi-asserted-by":"publisher","first-page":"1943","DOI":"10.1177\/1535370216659943","volume":"241","author":"MM Elseweidy","year":"2016","unstructured":"Elseweidy MM, Zein N, Aldhamy SE, Elsawy MM, Saeid SA. Policosanol as a new inhibitor candidate for vascular calcification in diabetic hyperlipidemic rats. Exp Biol Med. 2016;241(17):1943\u20139.","journal-title":"Exp Biol Med"},{"issue":"1","key":"4911_CR79","first-page":"31","volume":"21","author":"A Mirkin","year":"2001","unstructured":"Mirkin A, Mas R, Martinto M, Boccanera R, Robertis A, Poudes R, et al. Efficacy and tolerability of policosanol in hypercholesterolemic postmenopausal women. Int J Clin Pharmacol Res. 2001;21(1):31\u201341.","journal-title":"Int J Clin Pharmacol Res"},{"issue":"4","key":"4911_CR80","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.amjopharm.2004.12.004","volume":"2","author":"S Fern\u00e1ndez","year":"2004","unstructured":"Fern\u00e1ndez S, M\u00e1s R, Gamez R, Diaz A, Fern\u00e1ndez J, Deibis Orta S, et al. A pharmacological surveillance study of the tolerability of policosanol in the elderly population. Am J Geriatr Pharmacother. 2004;2(4):219\u201329.","journal-title":"Am J Geriatr Pharmacother"}],"container-title":["BMC Complementary Medicine and Therapies"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12906-025-04911-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12906-025-04911-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12906-025-04911-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,17]],"date-time":"2025-05-17T15:03:25Z","timestamp":1747494205000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccomplementalternmed.biomedcentral.com\/articles\/10.1186\/s12906-025-04911-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,17]]},"references-count":80,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4911"],"URL":"https:\/\/doi.org\/10.1186\/s12906-025-04911-0","relation":{},"ISSN":["2662-7671"],"issn-type":[{"value":"2662-7671","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,17]]},"assertion":[{"value":"20 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"182"}}